Journal
EXPERIMENTAL AND THERAPEUTIC MEDICINE
Volume 12, Issue 1, Pages 3-17Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/etm.2016.3293
Keywords
gastric mucosa; gastric mucosal barrier; gastric ulcer; probiotics; Helicobacter pylori; gastric ulcer prevention; gastric ulcer healing
Categories
Funding
- Emirates Foundation [2010/146]
- Sheikh Hamdan Award [MRG50/2011-12]
Ask authors/readers for more resources
Gastric ulcer is one of the most common chronic gastrointestinal diseases characterized by a significant defect in the mucosal barrier. Helicobacter pylori (H. pylori) infection and the frequent long-term use of non-steroidal antiinflam-matory drugs are major factors involved in gastric ulcer development. Acid inhibitors and antibiotics are commonly used to treat gastric ulcer. However, in the last few decades, the accumulating evidence for resistance to antibiotics and the side effects of antibiotics and acid inhibitors have drawn attention to the possible use of probiotics in the prevention and treatment of gastric ulcer. Probiotics are live microorganisms that when administered in adequate amounts confer health benefits on the host. Currently, the available experimental and clinical studies indicate that probiotics are promising for future applications in the management of gastric ulcers. This review aims to provide an overview of the general health benefits of probiotics on various systemic and gastrointestinal disorders with a special focus on gastric ulcer and the involved cellular and molecular mechanisms: i) Protection of gastric mucosal barrier; ii) upregulation of prostaglandins, mucus, growth factors and anti-inflammatory cytokines; iii) increased cell proliferation to apoptosis ratio; and iv) induction of angiogenesis. Finally, some of the available data on the possible use of probiotics in H. pylori eradication are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available